Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

This article is part of the supplement: Basic science, rationale, background and future of denosumab: a RANK ligand inhibitor

Highly Accessed Open Badges Review

Biology of RANK, RANKL, and osteoprotegerin

Brendan F Boyce* and Lianping Xing

Arthritis Research & Therapy 2007, 9(Suppl 1):S1  doi:10.1186/ar2165

Article Metrics

Total accesses

BioMed Central citations

Article metric FAQ


  • Last 30 days: 197 accesses
  • Last 365 days: 2236 accesses
  • All time: 18530 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information

Open Badges